Supriya Lifescience has opened a new multipurpose active pharmaceutical ingredient (API) production block in Maharashtra.

The facility located in Module E, at the Lote Parshuram site has been developed with an investment of approx. Rs 120 crore. This expansion boosts the Lote Parshuram capacity through an increase from 597 kilo liters per day (KLPD) to 932 KLPD. The new production block is designed to support Supriya’s focus on expanding its R&D capabilities and scaling up its pipeline of innovative products.

The facility is spread across 5,000 sq. mtrs. and structured over four levels, the facility enables efficient operations and safe workflows. The facility houses 33 reactors, comprising stainless steel and glass-lined varieties, with capacities ranging from 1.6 KL to 16 KL. It will support the company’s backward integration model, to reap economies of scale and retain a competitive edge. 

The new block will aid commercialisation of new products in niche therapeutic segments, and increase presence in key geographies.